Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study)

INTRODUCTION: Reducing dosing frequency may lower treatment burden and improve persistence and adherence. This retrospective, observational study assessed persistence and adherence in patients with type 2 diabetes (T2D) initiating once-weekly or daily injectable glucagon-like peptide-1 receptor agon...

Descripción completa

Detalles Bibliográficos
Autores principales: Polonsky, William H., Arora, Riya, Faurby, Mads, Fernandes, João, Liebl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776963/
https://www.ncbi.nlm.nih.gov/pubmed/34918213
http://dx.doi.org/10.1007/s13300-021-01189-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776963/
https://www.ncbi.nlm.nih.gov/pubmed/34918213
http://dx.doi.org/10.1007/s13300-021-01189-6

Ejemplares similares